SEER Inquiry System - Question 20041051 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 11/21/2025 2:10 AM

Question 20041051

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

SEER Book 8, 65

Question:

First Course Treatment/Immunotherapy--Colon: Can "Sandostatin" be coded for treatment of carcinoid tumors of the colon because it flushes tumor cells from the colon in addition to controlling diarrhea?

Discussion:

Answer:

Do not code Sandostatin (Ocreotide Acetate) as treatment. This is an ancillary drug used to treat symptoms of diarrhea. SEER Book 8 is undergoing revision and will include this change.

Cancer Site Category:

Colon

Data Item Category:

First course treatment, Immunotherapy

Other Category:

N/A

Year:

2004